With the rate of diabetes growing worldwide, it can feel like the condition is tough to avoid. A large Japanese study reveals ...

Type 1 diabetics have a lower risk of experiencing a cardiovascular event such as a stroke or heart attack than type 2 diabetics, a new study has found. It highlights the fundamental difference ...

More than 830 million people worldwide have diabetes—a chronic, debilitating disease. But experts say it’s possible to recover with a few proven lifestyle changes.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Aging is a natural process, but certain lifestyle choices can accelerate age-related diseases such as diabetes, heart disease ...

With diabetes rates climbing, an upcoming workshop series at the YMCA will provide valuable information and support to those combating the disease. The six-week series on diabetes self-management will ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, offering a new treatment option for cardiovascular protection. Sotagliflozin, a re ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

A new study has found a medication already used to treat people who have type 2 diabetes and/or chronic kidney disease with added heart disease risks also helps lower their stroke and heart attack ...